Ocular Therapeutix (NASDAQ:OCUL) rose 6% amid takeover speculation. There's speculation that a French pharmaceutical company is circling Ocular Therapeutix (NASDAQ:OCUL), according to traders, who cited a Betaville "uncooked" alert that was circulating on Friday.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.